Joan Merrill, M.D., is a recipient of the 2018 ACR Master designation, one of the highest honors members can receive.
news
OMRF adds three new researchers
The trio of scientists assumed their new positions at the foundation Nov. 1, bringing the total number of OMRF senior scientists to 49.
Oblato acquires all rights to glioblastoma drug from OMRF
Oblato, Inc., has acquired all rights from OMRF to OKN-007, an investigational drug for the treatment of a deadly form of brain cancer.
New findings cast light on lymphatic system, key player in human health
OMRF researchers have broken new ground in understanding how the lymphatic system works.
Putnam City Cancer Classic 5K scheduled for Nov. 3
The 11th annual Putnam City Cancer Classic will take place on Nov. 3 at Wheeler Park on the Oklahoma River.
OMRF recruiting volunteers for sarcoidosis research
OMRF’s Sarcoidosis Unit, which launched in January, is the only one of its kind in the state.
